Ironwood Pharmaceuticals, Inc.

Healthcare

NASDAQ:IRWD · NASDAQ Global Select

Market Cap $597.55M Beta 0.24 P/E (TTM) 5.8

$3.65 +0.55%

+$0.02 today

52W Low $0.62High $5.78

Vol 1.87M · Avg 2.49M

EPS (TTM)$0.63

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+488.71%

Period High

$5.39

Period Low

$0.62

Latest

$3.65

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

BioAge Labs, Inc.

NASDAQ:BIOA

$679.20M

NeuroPace, Inc.

NASDAQ:NPCE

$533.23M

Canopy Growth Corporation

NASDAQ:CGC

$425.84M

Silence Therapeutics plc

NASDAQ:SLN

$316.00M

Cellectis S.A.

NASDAQ:CLLS

$310.29M

Alpha Teknova, Inc.

NASDAQ:TKNO

$225.18M

Lifecore Biomedical, Inc.

NASDAQ:LFCR

$211.55M

Aurora Cannabis Inc.

NASDAQ:ACB

$172.40M

Genelux Corporation

NASDAQ:GNLX

$111.35M

Aldeyra Therapeutics, Inc.

NASDAQ:ALDX

$106.17M

What is the latest IRWD filing?

The latest filing shown is 4 dated May 21, 2026.

How many recent filings does IRWD have?

Intrinsic Alpha currently shows 20 recent filings for IRWD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.